Chadi Abbara

761 total citations
58 papers, 464 citations indexed

About

Chadi Abbara is a scholar working on Toxicology, Pharmacology and Clinical Psychology. According to data from OpenAlex, Chadi Abbara has authored 58 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Toxicology, 14 papers in Pharmacology and 10 papers in Clinical Psychology. Recurrent topics in Chadi Abbara's work include Forensic Toxicology and Drug Analysis (22 papers), Psychedelics and Drug Studies (10 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Chadi Abbara is often cited by papers focused on Forensic Toxicology and Drug Analysis (22 papers), Psychedelics and Drug Studies (10 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Chadi Abbara collaborates with scholars based in France, Switzerland and Türkiye. Chadi Abbara's co-authors include Laurence Bonhomme‐Faivre, Marie Briet, Robert Farinotti, Amine Benyamina, Bénédicte Lelièvre, Michel Reynaud, Alain Turcant, Alper Okyar, Francis Lévi and Jean Clairambault and has published in prestigious journals such as British Journal of Pharmacology, Biochemical Pharmacology and PLoS Computational Biology.

In The Last Decade

Chadi Abbara

51 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chadi Abbara France 12 102 94 94 82 54 58 464
Dolly A. Parasrampuria United States 15 111 1.1× 80 0.9× 22 0.2× 104 1.3× 29 0.5× 31 922
C Vidal Germany 11 97 1.0× 116 1.2× 44 0.5× 38 0.5× 25 0.5× 16 463
Louise Karlsson Sweden 14 59 0.6× 40 0.4× 74 0.8× 102 1.2× 90 1.7× 29 601
Christine Murphy United States 12 155 1.5× 86 0.9× 216 2.3× 18 0.2× 142 2.6× 30 588
Wei‐Jian Pan United States 14 83 0.8× 54 0.6× 72 0.8× 31 0.4× 13 0.2× 34 501
Czesław Żaba Poland 13 69 0.7× 87 0.9× 92 1.0× 16 0.2× 44 0.8× 60 510
Kyriaki Aroni Greece 14 51 0.5× 51 0.5× 101 1.1× 18 0.2× 103 1.9× 27 426
Matteo Moretti Italy 17 103 1.0× 47 0.5× 270 2.9× 15 0.2× 130 2.4× 45 649
Nele Sadones Belgium 7 74 0.7× 113 1.2× 102 1.1× 11 0.1× 25 0.5× 8 394
Jean‐Pierre Jourdan France 9 157 1.5× 48 0.5× 13 0.1× 37 0.5× 28 0.5× 18 507

Countries citing papers authored by Chadi Abbara

Since Specialization
Citations

This map shows the geographic impact of Chadi Abbara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chadi Abbara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chadi Abbara more than expected).

Fields of papers citing papers by Chadi Abbara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chadi Abbara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chadi Abbara. The network helps show where Chadi Abbara may publish in the future.

Co-authorship network of co-authors of Chadi Abbara

This figure shows the co-authorship network connecting the top 25 collaborators of Chadi Abbara. A scholar is included among the top collaborators of Chadi Abbara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chadi Abbara. Chadi Abbara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jousset, Nathalie, et al.. (2025). Accidental foodborne poisoning by atropine and scopolamine: a fatal case report. Journal of Forensic and Legal Medicine. 116. 102995–102995.
3.
Abbara, Chadi, et al.. (2024). In vitro β-hydroxybutyrate stability evaluation in femoral blood and vitreous humor for integration into forensic toxicology practices. Journal of Forensic and Legal Medicine. 107. 102764–102764.
4.
Picard, Nicolas, et al.. (2024). Tramadol intoxication in children: An emerging issue. Therapies. 79(6). 670–674. 1 indexed citations
5.
Hãhn, Oliver, et al.. (2024). Interest and limits of using pharmacogenetics in MDMA-related fatalities: A case report. Forensic Science International Genetics. 76. 103219–103219. 1 indexed citations
6.
Briet, Marie, et al.. (2024). Pharmacogenomics of 3,4-Methylenedioxymethamphetamine (MDMA): A Narrative Review of the Literature. Pharmaceutics. 16(8). 1091–1091. 2 indexed citations
7.
Abbara, Chadi, et al.. (2024). The interest of using vitreous humor for γ-hydroxybutyrate (GHB) quantification in related fatalities: Stability evaluation, case report and literature review. Journal of Forensic and Legal Medicine. 101. 102641–102641. 1 indexed citations
8.
Abbara, Chadi, et al.. (2024). Décès en lien avec des pharmacobézoards : à propos de deux cas. Annales de Toxicologie Analytique. 37(1). 53–61.
10.
Bejaud, Jérôme, Nolwenn Lautram, Florence Manero, et al.. (2021). New In Vitro Coculture Model for Evaluating Intestinal Absorption of Different Lipid Nanocapsules. Pharmaceutics. 13(5). 595–595. 8 indexed citations
11.
Picard, Nicolas, et al.. (2020). Pitfalls and challenges associated with phenoconversion in forensic toxcicology. Forensic Science International Genetics. 51. 102433–102433. 9 indexed citations
12.
Lloret‐Linares, Célia, Youssef Daali, Chadi Abbara, et al.. (2019). CYP450 activities before and after Roux-en-Y gastric bypass: correlation with their intestinal and liver content. Surgery for Obesity and Related Diseases. 15(8). 1299–1310. 13 indexed citations
13.
Valette, Xavier, et al.. (2015). Syndrome sérotoninergique sévère après ingestion d’α-méthyl-tryptamine (AMT). Annales de Toxicologie Analytique. 27(2). S25–S25. 2 indexed citations
14.
Abbara, Chadi, B. Estournet, Lucette Lacomblez, et al.. (2010). Riluzole pharmacokinetics in young patients with spinal muscular atrophy. British Journal of Clinical Pharmacology. 71(3). 403–410. 20 indexed citations
15.
Abbara, Chadi, et al.. (2010). Pharmacokinetic analysis of pralidoxime after its intramuscular injection alone or in combination with atropine‐avizafone in healthy volunteers. British Journal of Pharmacology. 161(8). 1857–1867. 18 indexed citations
16.
Abbara, Chadi, et al.. (2009). Bioavailability of diazepam after intramuscular injection of its water‐soluble prodrug alone or with atropine–pralidoxime in healthy volunteers. British Journal of Pharmacology. 157(8). 1390–1397. 13 indexed citations
17.
Hosten, Benoît, Chadi Abbara, Benoît Petit, et al.. (2009). Interleukin-2 treatment effect on imatinib pharmacokinetic, P-gp and BCRP expression in mice. Anti-Cancer Drugs. 21(2). 193–201. 4 indexed citations
18.
Bonhomme‐Faivre, Laurence, Amine Benyamina, Michel Reynaud, Robert Farinotti, & Chadi Abbara. (2008). PRECLINICAL STUDY: Disposition of Δ9tetrahydrocannabinol in CF1 mice deficient in mdr1a P‐glycoprotein. Addiction Biology. 13(3-4). 295–300. 32 indexed citations
19.
Hosten, Benoît, Chadi Abbara, Benoît Petit, et al.. (2008). Effect of Interleukin-2 Pretreatment on Paclitaxel Absorption and Tissue Disposition after Oral and Intravenous Administration in Mice. Drug Metabolism and Disposition. 36(8). 1729–1735. 6 indexed citations
20.
Abbara, Chadi, et al.. (2004). ENHANCED ORAL BIOAVAILABILITY OF PACLITAXEL BY RECOMBINANT INTERLEUKIN-2 IN MICE WITH MURINE LEWIS LUNG CARCINOMA. Drug metabolism and drug interactions. 20(4). 219–232. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026